Evidence map›Paper›PMID 38393319›Full record

ArticleeLife2024

An engineered biosensor enables dynamic aspartate measurements in living cells.

Kristian Davidsen, Jonathan S Marvin, Abhi Aggarwal, Timothy A Brown, Lucas B Sullivan

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Direct measurement of dynamic attractant gradients reveals breakdown of the Patlak-Keller-Segel chemotaxis model.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kristian DavidsenHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0002-3821-6902
Jonathan S MarvinHoward Hughes Medical Institute (HHMI), Janelia Research Campus, Ashburn, United States.ORCID https://orcid.org/0000-0003-2294-4515
Abhi AggarwalHoward Hughes Medical Institute (HHMI), Janelia Research Campus, Ashburn, United States.ORCID https://orcid.org/0000-0002-6336-566X
Timothy A BrownHoward Hughes Medical Institute (HHMI), Janelia Research Campus, Ashburn, United States.ORCID https://orcid.org/0000-0001-8941-7678
Lucas B SullivanHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, United States.ORCID https://orcid.org/0000-0002-6745-8222
Howard Hughes Medical Institute · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZA

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Understanding metabolic functions of mitochondria in proliferating cellsR35GM147118 · NIGMS · FRED HUTCHINSON CANCER CENTER · PI Lucas Bryan Sullivan · 2022 to 2026
$2.2M
NCI NIH HHS P30 CA015704NCI NIH HHS P30CA015704NIGMS NIH HHS R35 GM147118NIGMS NIH HHS R35GM147118
6 · The paper itself

Abstract

Intracellular levels of the amino acid aspartate are responsive to changes in metabolism in mammalian cells and can correspondingly alter cell function, highlighting the need for robust tools to measure aspartate abundance. However, comprehensive understanding of aspartate metabolism has been limited by the throughput, cost, and static nature of the mass spectrometry (MS)-based measurements that are typically employed to measure aspartate levels. To address these issues, we have developed a green fluorescent protein (GFP)-based sensor of aspartate (jAspSnFR3), where the fluorescence intensity corresponds to aspartate concentration. As a purified protein, the sensor has a 20-fold increase in fluorescence upon aspartate saturation, with dose-dependent fluorescence changes covering a physiologically relevant aspartate concentration range and no significant off target binding. Expressed in mammalian cell lines, sensor intensity correlated with aspartate levels measured by MS and could resolve temporal changes in intracellular aspartate from genetic, pharmacological, and nutritional manipulations. These data demonstrate the utility of jAspSnFR3 and highlight the opportunities it provides for temporally resolved and high-throughput applications of variables that affect aspartate levels.

Indexed as

Aspartic AcidBiosensing TechniquesAnimalsCell LineGreen Fluorescent ProteinsMammalsAspartic AcidGreen Fluorescent Proteinsaspartatebiochemistrybiosensorcell biologychemical biologyglutaminehumanmetabolismmitochondriaprotein engineering

Identifiers

PMID38393319
PMCPMC10942590
OpenAlexW4386326284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.